{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:04:52Z","timestamp":1788267892654,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bcp.2026.118202","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:45:56Z","timestamp":1782431156000},"page":"118202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Loganin triggers ferroptosis in renal cell carcinoma by targeting the IGF2BP2\/HMOX1 axis in an m6A-dependent manner"],"prefix":"10.1016","volume":"252","author":[{"given":"Fangzhen","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenliang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingliu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118202_b0005","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: a review","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2026.118202_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12929-024-01111-9","article-title":"Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma","volume":"32","author":"Pham","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bcp.2026.118202_b0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.eururo.2024.10.019","article-title":"First and second-line treatments in metastatic renal cell carcinoma","volume":"87","author":"Barragan-Carrillo","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bcp.2026.118202_b0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European Association of urology guidelines on renal cell carcinoma: the 2025 update","volume":"87","author":"Bex","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bcp.2026.118202_b0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.euo.2024.09.002","article-title":"Neoadjuvant and adjuvant immune-based approach for renal cell carcinoma: pros, cons, and future directions","volume":"8","author":"Marandino","year":"2025","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.bcp.2026.118202_b0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(24)00731-9","article-title":"Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis","volume":"26","author":"Huang","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2026.118202_b0035","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1001\/jamaoncol.2025.1891","article-title":"First-line therapy for advanced non-clear cell renal cell carcinoma: a systematic review and meta-analysis","volume":"11","author":"Petrelli","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bcp.2026.118202_b0040","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1142\/S0192415X24500253","article-title":"Traditional Chinese Medicine for cancer treatment","volume":"52","author":"Liu","year":"2024","journal-title":"Am. J. Chin. Med. (Gard. City. N. Y)"},{"key":"10.1016\/j.bcp.2026.118202_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116455","article-title":"Loganin alleviated cognitive impairment in 3\u00d7Tg-AD mice through promoting mitophagy mediated by optineurin","volume":"312","author":"Zhou","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.118202_b0050","article-title":"Loganin inhibits angiotensin II-induced cardiac hypertrophy through the JAK2\/STAT3 and NF-\u03baB signaling pathways","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118202_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154030","article-title":"Protective effect and mechanism of loganin and morroniside on acute lung injury and pulmonary fibrosis","volume":"99","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.118202_b0060","doi-asserted-by":"crossref","first-page":"9940","DOI":"10.48048\/tis.2025.9940","article-title":"Integrated In vitro and in silico exploration of bioactive compounds in strychnos lucida stem extract: revealing mechanisms against breast cancer","volume":"22","author":"Annisa","year":"2025","journal-title":"Trends in Sciences"},{"key":"10.1016\/j.bcp.2026.118202_b0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.118202_b0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2026.118202_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20517\/cdr.2024.151","article-title":"Ferroptosis-related signaling pathways in cancer drug resistance","volume":"8","author":"Yang","year":"2025","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bcp.2026.118202_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.818453","article-title":"Targeting cancer cell ferroptosis to reverse immune checkpoint inhibitor therapy resistance","volume":"10","author":"Deng","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2026.118202_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267399","article-title":"HMOX1 genetic polymorphisms and outcomes in infectious disease: a systematic review","volume":"17","author":"Hamilton","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118202_b0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40200-025-01575-y","article-title":"Association between microsatellite polymorphism in the Heme Oxygenase-1 (HMOX1) gene promoter and type 2 diabetes: an updated meta-analysis","volume":"24","author":"Rivera-Vald\u00e9s","year":"2025","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.bcp.2026.118202_b0095","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41467-025-56456-y","article-title":"Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma","volume":"16","author":"Zhou","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118202_b0100","article-title":"Donafenib and GSK-J4 synergistically induce ferroptosis in liver cancer by upregulating HMOX1 expression","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci. (Weinh)."},{"key":"10.1016\/j.bcp.2026.118202_b0105","article-title":"The emerging role of IGF2BP2 in cancer therapy resistance: from molecular mechanism to future potential","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118202_b0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s11658-025-00723-9","article-title":"IGF2BP2: an m6A reader that affects cellular function and disease progression","volume":"30","author":"Liu","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bcp.2026.118202_b0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13046-024-02959-3","article-title":"FBW7\/GSK3\u03b2 mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer","volume":"43","author":"Zhou","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118202_b0120","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.devcel.2024.12.011","article-title":"HMOX1-LDHB interaction promotes ferroptosis by inducing mitochondrial dysfunction in foamy macrophages during advanced atherosclerosis","volume":"60","author":"Peng","year":"2025","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcp.2026.118202_b0125","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1158\/0008-5472.CAN-24-3478","article-title":"Recharacterization of the tumor suppressive mechanism of RSL3 identifies the selenoproteome as a druggable pathway in colorectal cancer","volume":"85","author":"DeAngelo","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118202_b0130","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/ptr.7347","article-title":"Phytochemistry, synthesis, analytical methods, pharmacological activity, and pharmacokinetics of loganin: a comprehensive review","volume":"36","author":"Zhang","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bcp.2026.118202_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107529","article-title":"Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation","volume":"95","author":"Zhang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118202_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177993","article-title":"Loganin and morroniside: Therapeutic effects and molecular mechanisms in diabetes mellitus and its complications-a review","volume":"1003","author":"Jiang","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118202_b0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13046-024-02996-y","article-title":"KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma","volume":"43","author":"Cai","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118202_b0150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/j.gastro.2025.03.019","article-title":"Stromal Stiffness-Regulated IGF2BP2 in Pancreatic Cancer Drives Immune Evasion via Sphingomyelin Metabolism","volume":"169","author":"Tang","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2026.118202_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216826","article-title":"LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer","volume":"590","author":"Gao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.118202_b0160","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118202_b0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10020-023-00694-7","article-title":"Histone acetyltransferase P300 deficiency promotes ferroptosis of vascular smooth muscle cells by activating the HIF-1\u03b1\/HMOX1 axis","volume":"29","author":"Shi","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.bcp.2026.118202_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:22:41Z","timestamp":1786652561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S0006295226005411"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118202","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loganin triggers ferroptosis in renal cell carcinoma by targeting the IGF2BP2\/HMOX1 axis in an m6A-dependent manner","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118202"}}